Navigation Links
StemCor Systems Announces Acquisition of Intellectual Property to Enhance Bone Marrow Aspiration Platform
Date:12/6/2007

MENLO PARK, Calif., Dec. 6 /PRNewswire/ -- StemCor Systems, Inc., a medical device company developing systems for Enabling Regenerative Medicine(TM), announced today that it has acquired U.S. Patent 6,849,051, "Devices And Methods For Extraction of Bone Marrow", and associated know-how from USPure Sciences, LLC. The patent covers devices and methods for aspirating cellular samples from bone cavities. The concept and technologies are complementary to StemCor's MarrowMiner(TM) which recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market for the harvest of bone marrow.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071030/STEMCORSYSTEMSLOGO )

"We are pleased to add this patent and associated technologies to our bone marrow aspirating intellectual property portfolio," commented Vartan Ghazarossian, PhD, President and CEO of StemCor Systems, Inc. "By building upon the solid foundation of our current technologies, we plan to broaden our capabilities as we develop the systems to improve the harvesting of adult bone marrow for a variety of possible clinical applications in the field of Regenerative Medicine, including cardiovascular, neurologic, diabetic and orthopedic diseases."

About the MarrowMiner

The proprietary MarrowMiner system is designed to rapidly and easily harvest bone marrow in a minimally-invasive manner, in the outpatient setting, and without general anesthesia. The system consists of an access guide, a powered handle that drives a flexible atraumatic shaft through which marrow is aspirated, and an integrated marrow collection container. The MarrowMiner shaft gains access to the bone marrow cavity through the access guide to allow the removal of bone marrow through a single entry site. This is in contrast to the current practice of bone marrow aspiration through the insertion of a needle into multiple sites in the iliac crest of the hip, which usually requires general anesthesia, an operating room, and multiple clinical personnel. Preclinical studies demonstrated the ability of the MarrowMiner to safely harvest large volumes of marrow with significantly higher stem cell activity than is contained in standard needle aspirates.

About Bone Marrow

Bone marrow is a rich source of both adult stem and progenitor cells. Marrow-derived stem cells have been utilized extensively for over 40 years in the field of bone marrow transplantation, primarily for the treatment of a wide array of cancers and hematologic diseases for which over 60,000 transplants are performed each year. Orthopedic procedures, such as spinal fusions and the treatment of non-union fractures, also commonly utilize the patient's own bone marrow. More recently, marrow-derived cells are showing promise in the treatment of a widening array of diseases and conditions.

About Regenerative Therapies

Regenerative medicine focuses on the ability to repair or regenerate damaged, diseased or aging tissues, and is rapidly emerging as the next frontier in medicine. Regenerative therapies have the potential to provide effective therapies for millions of patients worldwide suffering from a wide array of diseases, including cardiovascular, neurologic, orthopedic and diabetic diseases. A critical aspect of many regenerative therapies is the ability to collect the patient's own stem cells, and later process, select and deliver these cells to a target organ.

About StemCor

StemCor Systems is a privately held medical device company located in the San Francisco Bay Area developing enabling technologies for regenerative medicine. The company's initial product is the MarrowMiner, a proprietary, minimally-invasive bone marrow collection system. The technology was invented by Daniel Kraft, MD, and was licensed exclusively from Stanford University. Clinical studies are now underway to evaluate the potential of the bone marrow collection system to obtain sufficient and high quality marrow-derived cells.

Contact: Vartan Ghazarossian, PhD

President and CEO

StemCor Systems, Inc.

650-321-6884

Vartan@StemCorSystems.com


'/>"/>
SOURCE StemCor Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System
2. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
3. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
4. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
5. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
6. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
7. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
8. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
9. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
10. Jon R. Wampler Joins Portico Systems Board of Directors
11. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... The Bell Agency, a full ... beneficiary of their ongoing community enrichment program. The current campaign fundraises for Angels ... are now being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... executive networking and relationship-marketing firm, announced today that nominations will be accepted ... Executive® (ISE®) West Awards. , Awards include the Information Security Executive® ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... a wide variety of organizations. DocuSyst provides a cloud hosted environment for ... Some installations include integration with various 3rd party applications using the FileHold web ...
(Date:2/8/2016)... MD (PRWEB) , ... February 08, 2016 , ... ... is excited to share this important news! AHCC and the Home Health and ... Coding Clinic, CMS' designee for official ICD coding guidance and clarifications, to address ...
(Date:2/8/2016)... ... February 08, 2016 , ... Guruji Mahendra Kumar Trivedi is ... 11th, 2016 in honor of his birthday on February 10th. During this time, ... Trivedi is known by over 250,000 people from over 40 different countries as an ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... YORK, Pa. , Feb. 8, 2016  Unilife Corporation ... developer and supplier of injectable drug delivery systems, today announced ... and six months ended December 31, 2015 after market close ... not scheduled a conference call to discuss these financial results.  ... About Unilife Corporation --> About Unilife ...
(Date:2/8/2016)... 8, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced that the U.S. Food and Drug Administration ... (IND) application for SB-318, a single treatment strategy ... Type I (MPS I). The SB-318 IND application ... a Phase 1/2 clinical study (SB-318-1502) designed to ...
(Date:2/8/2016)... Feb. 8, 2016  CTI BioPharma Corp. (CTI BioPharma) ... written communication from the U.S. Food and Drug Administration ... placed a partial clinical hold on the clinical studies ... application for pacritinib. This clinical hold impacts part of ... and will also affect planned clinical trials. ...
Breaking Medicine Technology: